Yoshihiro Komohara1,2, Tomohiro Miyamura3, Azusa Miyashita3, Hikaru Shigeta1, Takenobu Nakagawa1, Satoshi Fukushima3. 1. Department of Cell Pathology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. 2. Center for Metabolic Regulation of Healthy Aging, Kumamoto University, Kumamoto, Japan. 3. Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Abstract
Background: Recent developments in antibodies targeting checkpoint molecules have improved the overall survival of patients with melanoma. Case Report: A case of metastatic melanoma was treated with antibodies to cytotoxic T-lymphocyte-associated protein 4 and programmed cell death protein 1. Stable disease was achieved but the patient died from systemic metastasis 23 months after the diagnosis of melanoma. An autopsy was performed, and immunohistochemical analysis was carried out using primary melanoma (pre-treatment) and autopsy (post-treatment) samples. The down-regulation of human leukocyte antigen class I and II, melanin, and melanoma antigens was seen in the post-treatment tumor cells. Tumor-infiltrating lymphocyte numbers were significantly reduced in the post-treatment tumor microenvironment. Although programmed death ligand 1 expression was seen in the pre-treatment tumor tissues, it was not seen in the post-treatment tumor tissues. Conclusion: A phenotypical change in the tumor cells was suggested to be associated with the resistance to immune checkpoint inhibitor therapy. Copyright 2021, International Institute of Anticancer Research.
Background: Recent developments in antibodies targeting checkpoint molecules have improved the overall survival of patients with melanoma. Case Report: A case of metastatic melanoma was treated with antibodies to cytotoxic T-lymphocyte-associated protein 4 and programmed cell death protein 1. Stable disease was achieved but the patient died from systemic metastasis 23 months after the diagnosis of melanoma. An autopsy was performed, and immunohistochemical analysis was carried out using primary melanoma (pre-treatment) and autopsy (post-treatment) samples. The down-regulation of human leukocyte antigen class I and II, melanin, and melanoma antigens was seen in the post-treatment tumor cells. Tumor-infiltrating lymphocyte numbers were significantly reduced in the post-treatment tumor microenvironment. Although programmed death ligand 1 expression was seen in the pre-treatment tumor tissues, it was not seen in the post-treatment tumor tissues. Conclusion: A phenotypical change in the tumor cells was suggested to be associated with the resistance to immune checkpoint inhibitor therapy. Copyright 2021, International Institute of Anticancer Research.
Authors: James Larkin; Vanna Chiarion-Sileni; Rene Gonzalez; Jean-Jacques Grob; Piotr Rutkowski; Christopher D Lao; C Lance Cowey; Dirk Schadendorf; John Wagstaff; Reinhard Dummer; Pier F Ferrucci; Michael Smylie; David Hogg; Andrew Hill; Ivan Márquez-Rodas; John Haanen; Massimo Guidoboni; Michele Maio; Patrick Schöffski; Matteo S Carlino; Céleste Lebbé; Grant McArthur; Paolo A Ascierto; Gregory A Daniels; Georgina V Long; Lars Bastholt; Jasmine I Rizzo; Agnes Balogh; Andriy Moshyk; F Stephen Hodi; Jedd D Wolchok Journal: N Engl J Med Date: 2019-09-28 Impact factor: 91.245
Authors: Amber M Johnson; Bonnie L Bullock; Alexander J Neuwelt; Joanna M Poczobutt; Rachael E Kaspar; Howard Y Li; Jeff W Kwak; Katharina Hopp; Mary C M Weiser-Evans; Lynn E Heasley; Erin L Schenk; Eric T Clambey; Raphael A Nemenoff Journal: J Immunol Date: 2020-03-16 Impact factor: 5.422
Authors: Abdul Rafeh Naqash; Biagio Ricciuti; Dwight H Owen; Vaia Florou; Yukihiro Toi; Cynthia Cherry; Maida Hafiz; Andrea De Giglio; Mavish Muzaffar; Sandip H Patel; Shunichi Sugawara; Jarred Burkart; Wungki Park; Rita Chiari; Jun Sugisaka; Gregory A Otterson; Gilberto de Lima Lopes; Paul R Walker Journal: Cancer Immunol Immunother Date: 2020-03-05 Impact factor: 6.968
Authors: David Y Oh; Serena S Kwek; Siddharth S Raju; Tony Li; Elizabeth McCarthy; Eric Chow; Dvir Aran; Arielle Ilano; Chien-Chun Steven Pai; Chiara Rancan; Kathryn Allaire; Arun Burra; Yang Sun; Matthew H Spitzer; Serghei Mangul; Sima Porten; Maxwell V Meng; Terence W Friedlander; Chun Jimmie Ye; Lawrence Fong Journal: Cell Date: 2020-06-03 Impact factor: 41.582
Authors: Caroline Robert; Georgina V Long; Benjamin Brady; Caroline Dutriaux; Anna Maria Di Giacomo; Laurent Mortier; Piotr Rutkowski; Jessica C Hassel; Catriona M McNeil; Ewa Anna Kalinka; Céleste Lebbé; Julie Charles; Micaela M Hernberg; Kerry J Savage; Vanna Chiarion-Sileni; Catalin Mihalcioiu; Cornelia Mauch; Ana Arance; Francesco Cognetti; Lars Ny; Henrik Schmidt; Dirk Schadendorf; Helen Gogas; Jesús Zoco; Sandra Re; Paolo A Ascierto; Victoria Atkinson Journal: J Clin Oncol Date: 2020-09-30 Impact factor: 44.544